Table 2 Clinicopathological characteristics of the CRC patients in tissue arrays.
From: ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification
Characteristics | Low-ATP6AP1 | High-ATP6AP1 | p-value | Statistic |
|---|---|---|---|---|
n | 39 | 51 | Â | Â |
Sex, n (%) | Â | Â | 0.650 | 0.206 |
 Man | 18 (20%) | 26 (28.9%) |  |  |
 Female | 21 (23.3%) | 25 (27.8%) |  |  |
Age, median (IQR) | 69 (61, 79) | 71 (60, 79.5) | 0.839 | Â |
T, n (%) | Â | Â | 0.463 | 1.544 |
 T3 | 33 (36.7%) | 47 (52.2%) |  |  |
 T1 | 4 (4.4%) | 2 (2.2%) |  |  |
 T2 | 2 (2.2%) | 2 (2.2%) |  |  |
N, n (%) | Â | Â | 0.666 | 0.814 |
 N1 | 9 (10%) | 14 (15.6%) |  |  |
 N2 | 5 (5.6%) | 9 (10%) |  |  |
 N0 | 25 (27.8%) | 28 (31.1%) |  |  |
M, n (%) | Â | Â | 0.348 | 0.88 |
 M1 | 1 (1.1%) | 5 (5.6%) |  |  |
 M0 | 38 (42.2%) | 46 (51.1%) |  |  |
Pathologic.stage, n (%) | Â | Â | 0.812 | 0.056 |
 Stage II | 37 (41.1%) | 50 (55.6%) |  |  |
 Stage III | 2 (2.2%) | 1 (1.1%) |  |  |
